Lakefront Biotherapeutics (LKFT) EBT Margin (QoQ) (2016 - 2026)

Lakefront Biotherapeutics (LKFT) EBT Margin (QoQ) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Lakefront Biotherapeutics 1.85 Bn -1.64 Bn 1.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12,840.00
Dec 31, 2025 76,521.00
Sep 30, 2025 -91,837.00
Jun 30, 2025 44,864.00
Mar 31, 2025 -37,404.00
Dec 31, 2024 21,486.00
Sep 30, 2024 4,484.00
Jun 30, 2024 -13,094.00
Mar 31, 2024 7,480.00
Dec 31, 2023 -1,483.00
Sep 30, 2023 -74.00
Jun 30, 2023 -307.00
Mar 31, 2023 1,559.00
Dec 31, 2022 11,466.00
Sep 30, 2022 21,410.00
Jun 30, 2022 -28,338.00
Mar 31, 2022 -8,221.00
Dec 31, 2021 288,214.00
Sep 30, 2021 -283,385.00
Jun 30, 2021 -4,646.00